Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001457229 | SCV001661028 | likely benign | Hereditary spastic paraplegia 47 | 2024-10-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002421034 | SCV002721350 | likely benign | Inborn genetic diseases | 2018-11-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001457229 | SCV004050666 | likely benign | Hereditary spastic paraplegia 47 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003405676 | SCV004124233 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | AP4B1: BP4, BP7 |